Citi Pharma Limited (PSX:CPHL)

Citi Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	19,040	6,511	4,875	7,457	-	-
Market Cap Growth	275.46%	33.55%	-34.62%	-	-	-
Enterprise Value	20,663	6,236	4,443	5,627	-	-
Last Close Price	83.34	26.42	17.82	27.26	-	-
PE Ratio	22.91	7.81	7.41	11.41	-	-
PS Ratio	1.47	0.53	0.39	0.76	-	-
PB Ratio	3.42	1.16	0.91	1.58	-	-
P/TBV Ratio	3.42	1.16	0.91	1.58	-	-
P/FCF Ratio	-	8.46	-	-	-	-
P/OCF Ratio	-	4.87	-	-	-	-
EV/Sales Ratio	1.59	0.50	0.36	0.57	-	-
EV/EBITDA Ratio	14.20	4.65	3.53	5.28	-	-
EV/EBIT Ratio	15.99	5.17	3.81	5.66	-	-
EV/FCF Ratio	-18.87	8.11	-	-	-	-
Debt / Equity Ratio	0.53	0.26	0.34	0.20	0.07	0.49
Debt / EBITDA Ratio	2.02	1.08	1.46	0.88	0.50	1.57
Debt / FCF Ratio	-	1.89	-	-	-	-
Asset Turnover	1.07	1.16	1.37	1.34	1.29	1.86
Inventory Turnover	3.34	3.72	5.06	6.82	6.02	6.24
Quick Ratio	0.62	0.68	0.80	1.15	1.92	0.31
Current Ratio	1.24	1.36	1.48	1.86	2.45	1.11
Return on Equity (ROE)	15.04%	15.14%	13.05%	14.40%	13.16%	15.79%
Return on Assets (ROA)	6.69%	7.05%	8.06%	8.49%	7.96%	8.38%
Return on Capital (ROIC)	10.55%	10.54%	11.34%	12.01%	11.62%	12.00%
Return on Capital Employed (ROCE)	22.20%	20.60%	21.10%	19.40%	12.20%	20.80%
Earnings Yield	4.36%	12.80%	13.50%	8.77%	-	-
FCF Yield	-5.75%	11.82%	-26.33%	-12.38%	-	-
Dividend Yield	3.90%	12.30%	14.03%	-	-	-
Payout Ratio	89.39%	68.53%	-	47.66%	-	-
Buyback Yield / Dilution	-0.06%	-	-0.70%	-21.65%	-88.38%	-
Total Shareholder Return	3.84%	12.30%	13.32%	-21.65%	-88.38%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.